MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk



Status:Active, not recruiting
Conditions:Breast Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:21 - Any
Updated:8/4/2018
Start Date:July 2012
End Date:July 2019

Use our guide to learn which trials are right for you!

Epidemiology of MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk

The purpose of this study is to learn about how a woman's health history influences what a
normal breast looks like on an MRI. The investigators also want to learn about how the amount
of different natural hormones a woman has affects how the breast looks on an MRI. The
investigator's hope is that this will help to find women at a high-risk of breast cancer.


Inclusion Criteria:

- age 21 years or older

- be a cancer-free pre- or postmenopausal woman

- have no prior personal history of any cancer (including DCIS, excluding nonmelanoma
skin-cancer)

- able to speak and read English because the questionnaire is only available in English

- able to provide informed consent

Exclusion Criteria:

- are pregnant at the time of MRI

- have a prior personal history of any cancer (including DCIS, excluding nonmelanoma
skin cancer)
We found this trial at
1
site
1275 York Ave
New York, New York 10021
(212) 639-2000
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials